Pages that link to "Q36534829"
Jump to navigation
Jump to search
The following pages link to Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia (Q36534829):
Displaying 50 items.
- RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase (Q24291853) (← links)
- Downregulation of Cyclin G1 Expression by Retrovirus-Mediated Antisense Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation (Q28579573) (← links)
- RNA antisense abrogation of MAT1 induces G1 phase arrest and triggers apoptosis in aortic smooth muscle cells (Q28582065) (← links)
- Coordinate Notch3-hairy-related transcription factor pathway regulation in response to arterial injury. Mediator role of platelet-derived growth factor and ERK (Q28583973) (← links)
- Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals (Q30431522) (← links)
- Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-liposome system (Q30716866) (← links)
- A novel strategy of decoy transfection against nuclear factor-kappaB in myocardial preservation (Q32110662) (← links)
- Effective transfection of a cis element "decoy" of the nuclear factor-kappaB binding site into the experimental choroidal neovascularization (Q33185693) (← links)
- Potential for transcatheter application of antisense oligonucleotides for the treatment of vascular diseases (Q33568857) (← links)
- Gene therapy and vascular disease (Q33637644) (← links)
- Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo (Q33650305) (← links)
- Cardiovascular gene therapy (Q33838040) (← links)
- Gene therapy for peripheral arterial disease. (Q33946210) (← links)
- Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model (Q33959229) (← links)
- The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease (Q34030102) (← links)
- Delivery systems for antisense oligonucleotides (Q34047360) (← links)
- Therapeutic applications of transcription factor decoy oligonucleotides (Q34078075) (← links)
- Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides (Q34138108) (← links)
- Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model (Q34150085) (← links)
- A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo (Q34159206) (← links)
- Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme (Q34182616) (← links)
- Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth (Q34229552) (← links)
- The future of human gene therapy (Q34317814) (← links)
- Genetic engineering of vein grafts resistant to atherosclerosis (Q34339752) (← links)
- The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism (Q34407499) (← links)
- Local gene delivery to the vessel wall (Q34418987) (← links)
- Gene therapy in vascular medicine: recent advances and future perspectives (Q34453212) (← links)
- Augmented cell cycle protein expression and kinase activity in atherosclerotic rabbit vessels (Q34467100) (← links)
- The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides. (Q34473470) (← links)
- Genetic targeting of the renin-angiotensin system for long-term control of hypertension (Q34492788) (← links)
- Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene (Q34693858) (← links)
- Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide (Q34893888) (← links)
- Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering (Q34981655) (← links)
- Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. (Q34986363) (← links)
- Molecular approaches for the treatment of atherosclerosis (Q35020341) (← links)
- Effects of local delivery of trapidil on neointima formation in a rabbit angioplasty model (Q35041906) (← links)
- Gene Transfer Strategies to Inhibit Neointima Formation (Q35105875) (← links)
- Targeting the cell cycle machinery for the treatment of cardiovascular disease. (Q35164884) (← links)
- Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan). (Q35747709) (← links)
- In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer (Q35762528) (← links)
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty (Q35766125) (← links)
- Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent. (Q35787921) (← links)
- Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response (Q35801091) (← links)
- In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene (Q35871957) (← links)
- Cardiovascular gene delivery: The good road is awaiting (Q35915765) (← links)
- Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides (Q35935577) (← links)
- Gene therapy for the extension of vein graft patency: a review (Q36032833) (← links)
- Intratumoural administration of dendritic cells: hostile environment and help by gene therapy (Q36040788) (← links)
- Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells (Q36345732) (← links)
- The cell cycle: a critical therapeutic target to prevent vascular proliferative disease (Q36405134) (← links)